Kinetics of H2AX phosphorylation after exposure to cisplatin (Q39947163)

15 September 2017

Kinetics of H2AX phosphorylation after exposure to cisplatin (English)

1 reference

15 September 2017

0 references

1

Peggy L Olive

1 reference

15 September 2017

2

Judit P Banáth

1 reference

15 September 2017

1 March 2009

1 reference

Cytometry Part B: Clinical Cytometry

15 September 2017

1 reference

15 September 2017

76

1 reference

15 September 2017

79-90

1 reference

15 September 2017

2

1 reference

Mechanisms of resistance to cisplatin

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

DNA-protein crosslinking by trans-platinum(II)diamminedichloride in mammalian cells, a new method of analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

Recognition of cisplatin adducts by cellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Megabase chromatin domains involved in DNA double-strand breaks in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

H2AX: the histone guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, gamma -H2AX formation, and Mre11 relocalization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Assessing the likelihood of severe side effects in radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Molecular cloning of the human nucleotide-excision-repair gene ERCC4

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Residual gammaH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Cell Cycle-Dependent Expression of Phosphorylated Histone H2AX: Reduced Expression in Unirradiated but not X-Irradiated G1-Phase Cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

The comet assay: a method to measure DNA damage in individual cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Overnight lysis improves the efficiency of detection of DNA damage in the alkaline comet assay

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Interstrand cross-links of cisplatin induce striking distortions in DNA.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Detection of DNA double-strand breaks through the cell cycle after exposure to X-rays, bleomycin, etoposide and 125IdUrd

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

The role of DNA repair in the recovery of human cells from cisplatin toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20450

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20450

1 reference

15 September 2017

1 reference

PubMed ID

18727058